Pim-3原癌基因(PIM3)重组蛋白 Recombinant Pim-3 Oncogene (PIM3)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
Organism species | Homo sapiens (Human) |
Product No. | XY637Hu01 |
Source | Prokaryotic expression |
Host | E.coli |
Purity | > 95% |
UOM | 50ug |
Pim-3原癌基因(PIM3)重组蛋白Predicted Molecular Mass | 39.6kDa |
Concentration | n/a |
Applications | SDS-PAGE; WB; ELISA; IP. |
Endotoxin Level | <1.0EU per 1µg (determined by the LAL method) |
Residues | Met1~Leu326 with two N-terminal Tags, His-tag and T7-tag |
Formulation | Supplied as lyophilized form in PBS, pH7.4, containing 5% trehalose, 0.01% sarcosyl. |
SEQUENCES
Pim-3原癌基因(PIM3)重组蛋白The sequence of the target protein is listed below.
MLLSKFGSLA HLCGPGGVDH LPVKILQPAK ADKESFEKAY QVGAVLGSGG FGTVYAGSRI ADGLPVAVKH VVKERVTEWG SLGGATVPLE VVLLRKVGAA GGARGVIRLL DWFERPDGFL LVLERPEPAQ DLFDFITERG ALDEPLARRF FAQVLAAVRH CHSCGVVHRD IKDENLLVDL RSGELKLIDF GSGALLKDTV YTDFDGTRVY SPPEWIRYHR YHGRSATVWS LGVLLYDMVC GDIPFEQDEE ILRGRLLFRR RVSPECQQLI RWCLSLRPSE RPSLDQIAAH PWMLGADGGV PESCDLRLCT LDPDDVASTT SSSESL
USAGE
Reconstitute in sterile PBS, pH7.2-pH7.4.
STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Pim-3原癌基因(PIM3)重组蛋白Ready-to-use: No need to heat, dilute or add reducing agents before use.XY638Bo01内脂素(VF)重组蛋白Recombinant Visfatin (VF)Bos taurus; Bovine (Cattle)
XY638Hu01内脂素(VF)重组蛋白Recombinant Visfatin (VF)Homo sapiens (Human)
XY638Mu01内脂素(VF)重组蛋白Recombinant Visfatin (VF)Mus musculus (Mouse)
XY638Ra01内脂素(VF)重组蛋白Recombinant Visfatin (VF)Rattus norvegicus (Rat)
XY642Ra01果糖二磷酸醛缩酶A(ALDOA)重组蛋白Recombinant Aldolase A, Fructose Bisphosphate (ALDOA)Rattus norvegicus (Rat)
XY644Hu01CCAAT增强子结合蛋白α(CEBPα)重组蛋白Recombinant CCAAT/Enhancer Binding Protein Alpha (CEBPa)Homo sapiens (Human)
XY645Hu01晚期糖基化终末产物受体(AGER)重组蛋白Recombinant Advanced Glycosylation End Product Specific Receptor (AGER)Homo sapiens (Human)
XY645Mu01晚期糖基化终末产物受体(AGER)重组蛋白Recombinant Advanced Glycosylation End Product Specific Receptor (AGER)Mus musculus (Mouse)
XY646Hu01骨形成蛋白6(BMP6)重组蛋白Recombinant Bone MoXYogenetic Protein 6 (BMP6)Homo sapiens (Human)
XY646Mu01骨形成蛋白6(BMP6)重组蛋白Recombinant Bone MoXYogenetic Protein 6 (BMP6)Mus musculus (Mouse)
XY646Ra01骨形成蛋白6(BMP6)重组蛋白Recombinant Bone MoXYogenetic Protein 6 (BMP6)Rattus norvegicus (Rat)
XY647Hu01Smad同源物1(Smad1)重组蛋白Recombinant Mothers Against Decapentaplegic Homolog 1 (Smad1)Homo sapiens (Human)
XY647Ra01Smad同源物1(Smad1)重组蛋白Recombinant Mothers Against Decapentaplegic Homolog 1 (Smad1)Rattus norvegicus (Rat)
XY648Hu01Smad同源物7(Smad7)重组蛋白Recombinant Mothers Against Decapentaplegic Homolog 7 (Smad7)Homo sapiens (Human)
XY648Mu01Smad同源物7(Smad7)重组蛋白Recombinant Mothers Against Decapentaplegic Homolog 7 (Smad7)Mus musculus (Mouse)
XY648Ra01Smad同源物7(Smad7)重组蛋白Recombinant Mothers Against Decapentaplegic Homolog 7 (Smad7)Rattus norvegicus (Rat)
XY651Hu01透明质酸结合蛋白1(HABP1)重组蛋白Recombinant Hyaluronan Binding Protein 1 (HABP1)Homo sapiens (Human)
更新时间:2024/3/23 17:23:24